This fund is no longer traded. It was delisted on June 16, 2026. Prices stop on that date; discussion is still counted.
No summary has been written for this.
The REX LLY Growth & Income ETF is an exchange-traded fund designed to deliver a combination of leveraged equity exposure and regular income, specifically linked to the performance of Eli Lilly and Company (LLY) shares. Its primary function is to pay weekly distributions generated through a covered call strategy, where the fund sells call options on approximately half its notional LLY exposure, collecting premiums as potential income. The remaining half of the portfolio provides uncapped, leveraged exposure—ranging from 1.05x to 1.50x the daily percentage change of LLY—enabling greater participation in stock gains while the other half aims to generate regular income. Significantly, the ETF does not directly hold LLY stock; instead, it uses derivatives to create synthetic exposure, so investors are not entitled to LLY dividends or voting rights. Distributions may include a return of capital, and the fund’s structure means performance can deviate from LLY’s returns, particularly over periods longer than a single day due to leverage and compounding effects. The fund is engineered for knowledgeable investors seeking a balance of growth and income, and it carries a gross expense ratio of 0.99%. Active portfolio monitoring is essential due to the unique risks associated with leverage and options strategies.
No summary yet.
No summary yet.
No summary yet.
No summary yet.
No summary yet.
Investors talking about LLII also mention these. Each card shows that asset’s own numbers for the past 24 hours.